We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Bitter pill

21 September 2006

The German drugs and chemicals firm tried but failed to buy Schering this year. Its second choice, Serono, looks second rate. The Swiss firm relies on a handful of drugs and has been on the market for almost a year after other firms walked away.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)